(1 - 11 von 13
)
New GlaxoSmithKline CEO prepares for R&D choices, potential deals |...
www.reuters.com
Emma Walmsley, GlaxoSmithKline's incoming CEO, will take over Britain's biggest drugmaker at a challenging time but the 47-year-old also inherits the...
GlaxoSmithKline CEO Emma Walmsley downplays public speculation about...
www.healthcarefinancenews.com
The reports come as GSK also aligned with 23andMe on drug development work.
sortiert nach Relevanz / Datum